Results 241 to 250 of about 897,555 (284)
Some of the next articles are maybe not open access.
Treatment of Acinetobacter infections
Expert Opinion on Investigational Drugs, 1997Gram-negative non-fermentative aerobic bacilli are becoming increasingly more involved in nosocomial infections. It has generally been recognised that the members of the Acinetobacter genus are among the most common agents responsible for severe hospital infections; their clinical importance has increased due to the development of antibacterial ...
E Bergogne-Berezin
exaly +3 more sources
Acinetobacter Baumannii Nosocomial Infections [PDF]
Polish Journal of Surgery, 2013 Nosocomial infections caused by strains Acinetobacter baumannii strands are a growing clinical problem. The occurrence of multidrug-resistant strands is observed and that limits the ways of therapy considerably. The aim of the study was to determine the rate of infection and susceptibility spectrum of the species Acinetobacter baumannii isolated from ...
Karol, Sieniawski +4 more
openaire +3 more sources
Treatment of Acinetobacter spp. infections
Expert Opinion on Pharmacotherapy, 2003Acinetobacter spp. are predominantly nosocomial pathogens of growing importance. One of their important features is antimicrobial resistance that includes beta-lactams, aminoglycosides and quinolones. Imipenem, considered the most effective drug against Acinetobacter spp., is not universally active against clinical isolates and therapeutic options are ...
Anna S Levin
exaly +3 more sources
Acinetobacter Infection in the ICU
Critical Care Clinics, 2008Acinetobacter is a formidable challenge to managing critically ill patients. This pathogen's ability to rapidly develop antimicrobial resistance to all currently available antimicrobial agents is concerning because increasing data support attributable mortality to these bacteria when associated with hospitalized patients with comorbidities and severe ...
Clinton K, Murray, Duane R, Hospenthal
openaire +2 more sources
Community-acquired Acinetobacter infections
European Journal of Clinical Microbiology & Infectious Diseases, 2007Acinetobacter infections have been attracting increasing attention during recent years because they have become common in hospitalized patients, especially in the intensive care unit (ICU) setting. However, the available literature suggests that the pathogen has another fearful potential; it can cause community-acquired infections.
M E, Falagas +3 more
openaire +2 more sources
Managing Acinetobacter baumannii infections
Current Opinion in Infectious Diseases, 2019Purpose of review We reviewed recent data about epidemiology of Acinetobacter baumannii, resistance mechanisms, and therapeutic options for severe infections caused by multidrug-resistant strains. Recent findings A.
Garnacho-Montero, José +1 more
openaire +3 more sources
Infection with Acinetobacter in a burns unit
Burns, 1983In recent months 17 patients on the Burns Unit at St Lawrence Hospital have been infected with Acinetobacter anitratus. We present 4 patients who have been extremely ill and in whom Acinetobacter was considered to have played a prominent role. We stress the importance of opportunistic infection in burns patients and antibiotic resistance in this ...
A R, Green, M A, Milling
openaire +2 more sources
Treatment of Acinetobacter baumannii severe infections
Medicina Intensiva (English Edition), 2022Acinetobacter baumannii is a Gram-negative, multidrug-resistant (MDR) pathogen that causes nosocomial infections, especially in intensive care units (ICUs) and immunocompromised patients. A. baumannii has developed a broad spectrum of antimicrobial resistance, associated with a higher mortality rate among infected patients compared with other non ...
R, Reina +2 more
openaire +2 more sources
Phage therapy for Acinetobacter baumannii infection
2023Acinetobacter is a gram-negative nosocomial pathogenic bacteria. The contributing factor for the pathogenicity of Acinetobacter is severe due to its property of antibacterial drug resistance. Often antibiotic treatment is used to treat bacterial infection, however due to the resistance of a broad range of antibiotics by Acinetobacter the treatment ...
Ramneet, Kaur +2 more
openaire +2 more sources
Acinetobacter lwoffii infection and gastritis
Microbes and Infection, 2003About 25% of humans with chronic gastritis are negative for Helicobacter pylori, suggesting that other bacteria are capable of causing inflammation. Bacterial overgrowth may occur in the stomach under conditions of reduced acid secretion. In this review, we will explore what is generally known about non-H.
Sivaprakash, Rathinavelu +2 more
openaire +2 more sources